Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
Trial · NCT00908349
Adverse events23
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 23
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dizziness | Nervous system disorders | Oxcarbazepine XR | 33 | 214 | |
| other | Headache | Nervous system disorders | Oxcarbazepine XR | 24 | 214 | |
| other | Diplopia | Eye disorders | Oxcarbazepine XR | 20 | 214 | |
| other | Nausea | Gastrointestinal disorders | Oxcarbazepine XR | 16 | 214 | |
| other | Vomiting | Gastrointestinal disorders | Oxcarbazepine XR | 13 | 214 | |
| other | Somnolence | Nervous system disorders | Oxcarbazepine XR | 12 | 214 | |
| other | Balance Disorder | Nervous system disorders | Oxcarbazepine XR | 10 | 214 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | Oxcarbazepine XR | 10 | 214 | |
| serious | Hypothermia | General disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Spinal Fracture | Injury, poisoning and procedural complications | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Ataxia | Nervous system disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Transient Ischaemic Attack | Nervous system disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Dizziness | Nervous system disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Convulsion | Nervous system disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Prostatic Specific Antigen Increased | Investigations | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Nephrolithiasis | Renal and urinary disorders | Oxcarbazepine XR | 1 | 214 | 1 |
| serious | Grand Mal Convulsion | Nervous system disorders | Oxcarbazepine XR | 2 | 214 | 2 |
| serious | Non-Cardiac Chest Pain | General disorders | Oxcarbazepine XR | 2 | 214 | 2 |
| serious | Epilepsy | Nervous system disorders | Oxcarbazepine XR | 2 | 214 | 2 |
| serious | Suicidal Behaviour | Psychiatric disorders | Oxcarbazepine XR | 1 | 214 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00908349/events